These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24081825)

  • 1. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro.
    Padilla-S L; Rodríguez A; Gonzales MM; Gallego-G JC; Castaño-O JC
    Arch Virol; 2014 Mar; 159(3):573-9. PubMed ID: 24081825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.
    Mounce BC; Cesaro T; Carrau L; Vallet T; Vignuzzi M
    Antiviral Res; 2017 Jun; 142():148-157. PubMed ID: 28343845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of doxycycline against dengue virus replication in vitro.
    Rothan HA; Mohamed Z; Paydar M; Rahman NA; Yusof R
    Arch Virol; 2014 Apr; 159(4):711-8. PubMed ID: 24142271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Action of Curcumin Encapsulated in Nanoemulsion against Four Serotypes of Dengue Virus.
    Nabila N; Suada NK; Denis D; Yohan B; Adi AC; Veterini AS; Anindya AL; Sasmono RT; Rachmawati H
    Pharm Nanotechnol; 2020; 8(1):54-62. PubMed ID: 31858909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.
    Si X; Wang Y; Wong J; Zhang J; McManus BM; Luo H
    J Virol; 2007 Apr; 81(7):3142-50. PubMed ID: 17229707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway.
    Kim K; Kim KH; Kim HY; Cho HK; Sakamoto N; Cheong J
    FEBS Lett; 2010 Feb; 584(4):707-12. PubMed ID: 20026048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication.
    Poh MK; Shui G; Xie X; Shi PY; Wenk MR; Gu F
    Antiviral Res; 2012 Jan; 93(1):191-8. PubMed ID: 22146564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference mediated silencing of Hsp60 gene in human monocytic myeloma cell line U937 revealed decreased dengue virus multiplication.
    Padwad YS; Mishra KP; Jain M; Chanda S; Karan D; Ganju L
    Immunobiology; 2009; 214(6):422-9. PubMed ID: 19261350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dengue virus by curcuminoids.
    Balasubramanian A; Pilankatta R; Teramoto T; Sajith AM; Nwulia E; Kulkarni A; Padmanabhan R
    Antiviral Res; 2019 Feb; 162():71-78. PubMed ID: 30529358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of glutathione on dengue virus production.
    Tian Y; Jiang W; Gao N; Zhang J; Chen W; Fan D; Zhou D; An J
    Biochem Biophys Res Commun; 2010 Jul; 397(3):420-4. PubMed ID: 20510876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro.
    Charnsilpa W; Takhampunya R; Endy TP; Mammen MP; Libraty DH; Ubol S
    J Med Virol; 2005 Sep; 77(1):89-95. PubMed ID: 16032750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells.
    Chen LC; Yeh TM; Wu HN; Lin YY; Shyu HW
    J Infect; 2008 Feb; 56(2):143-50. PubMed ID: 18076993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ribavirin and hydroxyurea on oral infection of Aedes aegypti (L.) with dengue virus.
    Lee HL; Phong TV; Rohani A
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1358-64. PubMed ID: 23413698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein.
    Ishag HZ; Li C; Huang L; Sun MX; Ni B; Guo CX; Mao X
    Virus Res; 2013 Jan; 171(1):89-96. PubMed ID: 23142554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.
    Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H
    Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference in dengue virus adsorption and uncoating by carrageenans.
    Talarico LB; Damonte EB
    Virology; 2007 Jul; 363(2):473-85. PubMed ID: 17337028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes.
    Puerta-Guardo H; Medina F; De la Cruz Hernández SI; Rosales VH; Ludert JE; del Angel RM
    Antiviral Res; 2012 Apr; 94(1):57-61. PubMed ID: 22387385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
    Arévalo MT; Simpson-Haidaris PJ; Kou Z; Schlesinger JJ; Jin X
    J Med Virol; 2009 Mar; 81(3):519-28. PubMed ID: 19152413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.